Related Experiment Video
Updated: Jul 28, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Doxepin plasma levels and anxiolytic response
International Pharmacopsychiatry
|January 1, 1980
Summary
This study found no significant correlation between doxepin levels and anxiety symptom reduction in patients treated with doxepin. Dosing adjustments based on blood levels did not appear to directly impact anxiety scores in this trial.
Area of Science:
- Psychiatry
- Clinical Pharmacology
Background:
- Anxiety disorders are prevalent and often treated with tricyclic antidepressants like doxepin.
- Understanding the relationship between drug concentration and clinical efficacy is crucial for optimizing treatment.
Purpose of the Study:
- To investigate the correlation between plasma concentrations of doxepin and its active metabolite, desmethyl-doxepin, and anxiety symptom severity.
- To assess the impact of a flexible dosage regimen of doxepin on anxiety symptoms.
Main Methods:
- A study involving 23 patients diagnosed with anxiety, treated with a flexible dosage of doxepin.
- Hamilton Anxiety Rating Scale (HAM-A) scores were measured at baseline and on days 7, 14, and 21.
- Plasma concentrations of doxepin and desmethyl-doxepin were analyzed on days 7, 14, and 21.
Main Results:
- No significant correlation was observed between plasma doxepin concentrations and HAM-A scores at day 21 (rs = -0.099, p > 0.05).
- Similarly, no significant correlation was found between desmethyl-doxepin concentrations and HAM-A scores at day 21 (rs = 0.339, p > 0.05).
- The sum of doxepin and desmethyl-doxepin concentrations also did not correlate with HAM-A scores at day 21 (rs = 0.276, p > 0.05), nor on earlier assessment days.
Conclusions:
- Plasma concentrations of doxepin and desmethyl-doxepin do not appear to correlate with anxiety symptom severity in patients treated with a flexible dosage regimen.
- Further research is needed to elucidate the relationship between doxepin pharmacokinetics and clinical outcomes in anxiety disorders.
More Related Videos
07:54Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
Published on: June 29, 2018
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Related Concept Videos
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...